Search for a trial

Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety And Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years

This study has been transitioned to CTIS with ID 2023-506589-30-00 check the CTIS register for the current data. The purpose of this study is to demonstrate the efficacy of 9-valentextraintestinal pathogenic Escherichia coli vaccine (ExPEC9V)…